Anti-cd18 antibodies for use against stroke

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2242414

A method for improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size is described which involves administering an effective amount of an anti-CD18 antibody to the mammal, in the absence of removal of the arterial obstruction.

Cette invention se rapporte à un procédé permettant d'améliorer les résultats cliniques s'agissant de l'attaque ischémique focale chez un mammifère, par accroissement du flux sanguin cérébral et/ou réduction de la taille de l'infarctus cérébral. Ledit procédé consiste à administrer audit mammifère une quantité efficace d'un anticorps dirigé contre le CD18, et ce sans retrait de l'obstruction artérielle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-cd18 antibodies for use against stroke does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cd18 antibodies for use against stroke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cd18 antibodies for use against stroke will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1572646

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.